Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
Kita Y, Hamada A, Saito R, Teramoto Y, Tanaka R, Takano K, Nakayama K, Murakami K, Matsumoto K, Akamatsu S, Yamasaki T, Inoue T, Tabata Y, Okuno Y, Ogawa O, Kobayashi T.
Kita Y, et al. Among authors: nakayama k.
Br J Cancer. 2019 Dec;121(12):1027-1038. doi: 10.1038/s41416-019-0609-0. Epub 2019 Nov 1.
Br J Cancer. 2019.
PMID: 31673101
Free PMC article.